↓ Skip to main content

Kava extract versus placebo for treating anxiety

Overview of attention for article published in Cochrane database of systematic reviews, January 2003
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (97th percentile)
  • High Attention Score compared to outputs of the same age and source (86th percentile)

Mentioned by

news
2 news outlets
blogs
2 blogs
twitter
2 tweeters
facebook
1 Facebook page
wikipedia
3 Wikipedia pages
video
1 video uploader

Citations

dimensions_citation
48 Dimensions

Readers on

mendeley
68 Mendeley
citeulike
1 CiteULike
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Kava extract versus placebo for treating anxiety
Published in
Cochrane database of systematic reviews, January 2003
DOI 10.1002/14651858.cd003383
Pubmed ID
Authors

Max H Pittler, Edzard Ernst

Abstract

Constraints on resources and time often render treatments for anxiety such as psychological interventions impracticable, while synthetic anxiolytic drugs are effective, but are often burdened with adverse events. Options which are effective and safe would be of considerable interest and a welcome addition to the therapeutic repertoire.

Twitter Demographics

The data shown below were collected from the profiles of 2 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 68 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 68 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 1 1%
Unknown 67 99%
Readers by discipline Count As %
Physics and Astronomy 1 1%
Unknown 67 99%

Attention Score in Context

This research output has an Altmetric Attention Score of 33. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 April 2019.
All research outputs
#470,815
of 12,991,173 outputs
Outputs from Cochrane database of systematic reviews
#1,496
of 10,439 outputs
Outputs of similar age
#5,435
of 213,198 outputs
Outputs of similar age from Cochrane database of systematic reviews
#72
of 534 outputs
Altmetric has tracked 12,991,173 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 96th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 10,439 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 20.5. This one has done well, scoring higher than 85% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 213,198 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 97% of its contemporaries.
We're also able to compare this research output to 534 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 86% of its contemporaries.